Purpose To investigate the anatomic basis of atypical angiographic leaks in central serous chorioretinopathy (CSC) with optical coherence tomography (OCT). Methods Fluorescein angiography (FA) and OCT were performed in three eyes of three patients (two men, one woman) with CSC.
Introduction
The most commonly described patterns of fluorescein leakage in central serous chorioretinopathy (CSC) are 'inkblot' and 'smokestack,' accounting for 93 and 7% of cases, respectively. 1 Other rarer forms of angiographic leakage have been referred to as 'leaking scar,' 'blowout,' and 'diffuse leakage.' [2] [3] [4] In this case series, optical coherence tomography (OCT) findings were identified, which might account for an unusual angiographic leakage pattern observed in three patients over the course of CSC.
Materials and methods
Patients presenting with visual loss due to CSC at a tertiary eye care centre underwent bestcorrected visual acuity (BCVA) measurement, dilated fundus examination, and fluorescein angiography (FA). The patients who demonstrated unfamiliar patterns of dye leakage on FA were evaluated with OCT (StratusOCT, Carl Zeiss Meditec, Dublin, CA, USA). Depending on the location of leakage, photodynamic therapy (PDT), transpupillary thermotherapy (TTT), or photocoagulation was considered. The study was approved by the Institutional Review Board; informed consent was obtained from each patient. The primary outcome measure was the correlation of the FA and OCT findings. Figure 1c ). The bridging tissue appeared to belong to the outer retinal layers, attached to PED at two foci. Intervention was considered appropriate, given the duration of CSC. Photocoagulation was deemed unsafe for the juxtafoveal leakage. PDT was not acceptable to the patient because of financial constraints. In view of the authors' experience with TTT in this condition, 5 TTT was also offered, and accepted by the patient. Subthreshold TTT was performed with an 810 nm diode laser (OcuLight SLX, Iridex, CA, USA): 2 mm spot at 160 mW for 1 min.
Results

Of
One-month post-TTT, BCVA improved to 20/60, with partially regressed CSC and no clinically evident PED. FA revealed the conversion of the anomalous leak into a classic 'smokestack' configuration arising from the same focus (Figure 1d ). OCT confirmed PED resolution and disappearance of the bridging tissue with excellent preservation of retinal structure (Figure 1e) . Two months later, vision had improved to 20/20 and normal macular contours were restored (Figure 1f ). Status quo was maintained for 24 months. (Figure 2a) . These leaks were observed early in the angiogram and did not arise from focal locations. Multiple PEDs were also observed. A horizontal OCT scan through the lower portion of the right macula revealed multiple bands of tissue connecting the CSC to the PED (Figure 2b ). This patient also underwent TTT centred over the lower portion of the vertical leaks (260 mW; 3 mm spot; 1 min). Three months later, the serous detachment had resolved 
Case 3
A 43-year-old man was treated elsewhere with oral steroids (1 mg/kg/day) for presumed ischaemic optic neuropathy OS. He noticed a drop in vision OD after 1 month of steroid treatment, and presented with BCVA of 20/60 OD and 20/200 OS. Fundus examination revealed a CSC OD and disc pallor OS. FA revealed multiple PEDs OD, with an oblique curvilinear band of leakage at the superior edge of the PED superonasal to fovea (Figure 3a) . OCT through the superior PEDs demonstrated retinal attachment to the roof of the PEDs (Figure 3b) . The steroids were stopped; but findings persisted 2 months later. The patient declined photocoagulation.
Discussion
Iida et al 6 described OCT findings in three eyes with CSC where a 'reflective mass,' thought to represent subretinal fibrin, bridged the detached retina to the underlying PED. They did not correlate leakage pattern with this finding nor comment on how such a finding might affect leakage morphology. 6 In the present case series, subretinal fibrin was clinically evident in only case 2; however, bridging retinal tissue was present in all. We are unaware of any report of such correlation between OCT findings ('bridging tissue') and abnormal leakage patterns in CSC.
It is possible that the angiographic leakage patterns reflect the underlying anatomical changes observed by OCT. Such a mechanism is supported by the 1-month post-treatment follow-up observations in case 1 (Figure 1d and e) . While the bridging tissue was present, the angiographic leakage pattern was atypical; but posttreatment, when the bridging tissue was no longer present but the detachment remained, the atypical leakage converted to a typical 'smokestack.' It is possible that the leakage pattern within the serous detachment could be altered by such bridging tissue due to loculation of the serous cavity, altered fluid current dynamics, physical location in the leakage path, etc. When this physical impediment is removed, the leakage pattern assumes a more typical configuration. The risk factors and mechanisms predisposing to this anatomical change are not known and indeed may vary depending upon ethnicity or other characteristics of a particular patient population. These findings demonstrate the potential usefulness of OCT as an adjunct to FA in suggesting an anatomic basis for anomalous leakage patterns in CSC. Further study is needed to determine whether the clinical outcome or response to treatment is substantially different in this group of patients. 
